oxycodone and aspirin (42806-061)

Drug Facts

Product Profile

Brand Name oxycodone and aspirin

Generic Name oxycodone and aspirin

Labeler epic pharma, llc

Dosage Form TABLET

Routes

ORAL

Active Ingredients

aspirin 325 mg/1, oxycodone hydrochloride 4.8355 mg/1

Manufacturer

Epic Pharma, LLC

Identifiers & Regulatory

Product NDC 42806-061

Product ID 42806-061_8cd322df-f304-482e-9ed5-a7afa26f5645

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA040910

DEA Schedule cii

Listing Expiration 2026-12-31

Marketing Start 2020-06-30

Pharmacologic Class

Established (EPC)

nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]

Mechanism of Action

cyclooxygenase inhibitors [moa]

Chemical Structure

anti-inflammatory agents, non-steroidal [cs]

Physiologic Effect

decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42806061

Hyphenated Format 42806-061

Supplemental Identifiers

RxCUI

848768

UPC

0342806061015

UNII

R16CO5Y76E C1ENJ2TE6C

NUI

N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxycodone and aspirin (source: ndc)

Generic Name oxycodone and aspirin (source: ndc)

Application Number ANDA040910 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

325 mg/1
4.8355 mg/1

source: ndc

Packaging

100 TABLET in 1 BOTTLE (42806-061-01)

source: ndc

Packages (1)

42806-061-01 100 TABLET in 1 BOTTLE (42806-061-01)

Ingredients (2)

aspirin (325 mg/1) oxycodone hydrochloride (4.8355 mg/1)

Linked Drug Pages (1)

Oxycodone and Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "8cd322df-f304-482e-9ed5-a7afa26f5645", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0342806061015"], "unii": ["R16CO5Y76E", "C1ENJ2TE6C"], "rxcui": ["848768"], "spl_set_id": ["3292a7c6-5ba3-4563-bc62-e43040634123"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Epic Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (42806-061-01)", "package_ndc": "42806-061-01", "marketing_start_date": "20200630"}], "brand_name": "Oxycodone and Aspirin", "product_id": "42806-061_8cd322df-f304-482e-9ed5-a7afa26f5645", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42806-061", "dea_schedule": "CII", "generic_name": "Oxycodone and Aspirin", "labeler_name": "Epic Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxycodone and Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "OXYCODONE HYDROCHLORIDE", "strength": "4.8355 mg/1"}], "application_number": "ANDA040910", "marketing_category": "ANDA", "marketing_start_date": "20200630", "listing_expiration_date": "20261231"}